Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.27 | N/A |
| PEG Ratio (TTM) | -0.21 | N/A |
| P/S Ratio (TTM) | 0.11 | N/A |
| P/B Ratio (TTM) | 0.47 | N/A |
| P/FCF Ratio (TTM) | -2.12 | N/A |
| Price to 5YR AVG Earnings Ratio | 4.97 | N/A |
| Price to 5YR AVG FCF Ratio | 12.37 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.44% | N/A |
| ROE (TTM) | 4.60% | N/A |
| Net Profit Margin (TTM) | 1.09% | N/A |
| ROIC 5YR AVG | 9.94% | N/A |
Growth (73%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -22.17% | 96.57% | 70.57% |
| Revenue | 1.16% | 10.97% | 17.36% |
| Net Income | -21.91% | 98.16% | 71.52% |
| Cash Flow | 87.20% | 5,969.56% | 3,483.41% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.32 | N/A |
| Quick Ratio (TTM) | 0.15 | N/A |
| D/E Ratio (TTM) | 0.08 | N/A |
| Interest Coverage (TTM) | 1.69 | N/A |
| Piotroski F-Score | 2 | N/A |
| Altman Z-Score | 2.09 | N/A |
| LTL to 5YR AVG FCF | 5.76 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.62% | N/A |